PUBLISHER: Grand View Research | PRODUCT CODE: 1268770
PUBLISHER: Grand View Research | PRODUCT CODE: 1268770
The global dermal fillers market size is anticipated to reach USD 12.2 billion by 2030, registering a CAGR of 8.7% over the forecast period, according to the new report of Grand View Research, Inc. Dermal fillers are soft tissue injectables that are injected into different depths of the skin and assist in treating signs of aging, loss of volume, facial contouring, etc. The ever-rising demand for aesthetic treatments that are safe and effective, increasing focus on appearance, rising disposable income, and growing geriatric population are expected to boost the market growth. As per the American Society of Plastic Surgeons, dermal fillers differ in chemical makeup and longevity and have varying degrees of softness.
For example, softer fillers are used on the lips, while sturdier fillers areused to enhance cheekbones. The ASPS reported that in 2020, around 2,619,650 hyaluronic acid dermal filler treatments were carried out in the U.S, and brands like Juvederm Ultra, Juvederm Ultra Plus, Perlane, Restylane, Belotero were the most preferred.The product demand is expected to increase significantly due to the fact that it provides desired results for individuals and can also be reversed if the patient is not satisfied with the results.
Growing social media influence, high consciousness about aesthetic appearance, and its association with self-confidence and self-image by an individual are some of the factors driving the market growth.In light of COVID-19, the market was hampered as the footfall of patient appointments for aesthetic treatments was temporarily suspended during the first half of 2020. However, the demand has been on the rise post-pandemic. Moreover, according to the BBC network, inquiries and appointments for many surgical and non-surgical cosmetic treatments have seen a surge following the pandemic and are thus expected to boost the market growth.